We are live on ! Find out more
VAIA

Virtus Alternative Investment Advisers Portfolio holdings

AUM $6.71M
1-Year Est. Return 36.98%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+36.98%
3 Year Est. Return
+42.83%
5 Year Est. Return
10 Year Est. Return
AUM
$6.65M
AUM Growth
+$2.01M
Cap. Flow
+$1.84M
Cap. Flow %
27.65%
Top 10 Hldgs %
67.61%
Holding
250
New
239
Increased
2
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$132K
2
TRU icon
TransUnion
TRU
+$123K
3
MRSH
Marsh
MRSH
+$90K
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$86.7K
5
BRO icon
Brown & Brown
BRO
+$30.7K

Sector Composition

Rank Sector Weight
1 Industrials 10.77%
2 Healthcare 7.43%
3 Technology 7.05%
4 Financials 5.34%
5 Consumer Discretionary 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCY icon
1
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
$1.89M 28.45%
63,969
-6,188
-9% -$180K
EMB icon
2
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$1.88M 28.33%
16,442
-1,484
-8% -$168K
EFX icon
3
Equifax
EFX
$22B
$134K 2.02%
+953
New +$132K
TRU icon
4
TransUnion
TRU
$16.2B
$127K 1.91%
+1,481
New +$123K
MU icon
5
Micron Technology
MU
$924B
$102K 1.53%
1,898
-549
-22% -$26.2K
MRSH
6
Marsh
MRSH
$91.8B
$96K 1.44%
+862
New +$90K
AJG icon
7
Arthur J. Gallagher & Co
AJG
$67.7B
$90K 1.35%
+947
New +$86.7K
WSO icon
8
Watsco Inc
WSO
$13.2B
$74K 1.11%
411
+50
+14% +$8.79K
LII icon
9
Lennox International
LII
$15.7B
$65K 0.98%
267
+35
+15% +$8.68K
BRO icon
10
Brown & Brown
BRO
$24.5B
$32K 0.48%
+817
New +$30.7K
AM icon
11
Antero Midstream
AM
$10.3B
$14K 0.21%
+1,851
New +$11.7K
GBT
12
DELISTED
Global Blood Therapeutics, Inc.
GBT
$13K 0.2%
+160
New +$9.48K
ARWR icon
13
Arrowhead Research
ARWR
$12.1B
$12K 0.18%
+184
New +$9.13K
NG icon
14
NovaGold Resources
NG
$2.52B
$12K 0.18%
+1,286
New +$8.9K
HQY icon
15
HealthEquity
HQY
$8.54B
$11K 0.17%
+144
New +$8.98K
WING icon
16
Wingstop
WING
$3.81B
$11K 0.17%
+122
New +$10.1K
XLRN
17
DELISTED
Acceleron Pharma
XLRN
$11K 0.17%
+205
New +$9.35K
MYOK
18
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$11K 0.17%
+155
New +$9.4K
A icon
19
Agilent Technologies
A
$39.9B
$10K 0.15%
+113
New +$8.9K
ADUS icon
20
Addus HomeCare
ADUS
$2.24B
$10K 0.15%
+101
New +$8.89K
ALG icon
21
Alamo Group
ALG
$1.98B
$10K 0.15%
+78
New +$9.12K
AMED
22
DELISTED
Amedisys
AMED
$10K 0.15%
+58
New +$8.63K
BMI icon
23
Badger Meter
BMI
$3.85B
$10K 0.15%
+149
New +$8.84K
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$11.9B
$10K 0.15%
+115
New +$8.69K
CGNX icon
25
Cognex
CGNX
$9.99B
$10K 0.15%
+177
New +$9.15K

Similar funds

Virtus Alternative Investment Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Virtus Alternative Investment Advisers held 250 positions worth $6.65M, up 43% from $4.64M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Virtus Alternative Investment Advisers deployed $1.84M of net new capital in Q4 2019, opening 239 new positions and adding to 2 existing holdings. Its largest new stake was Equifax: 953 shares worth $134K.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, up from 2.5% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Invesco Emerging Markets Sovereign Debt ETF, an estimated $180K trimmed.

  • Virtus Alternative Investment Advisers's largest Q4 2019 buy was Equifax: 953 shares worth $134K.
  • Virtus Alternative Investment Advisers added most to Watsco Inc in Q4 2019, an estimated $8.79K increase.
  • Virtus Alternative Investment Advisers's biggest Q4 2019 reduction was Invesco Emerging Markets Sovereign Debt ETF, cutting an estimated $180K.
  • Virtus Alternative Investment Advisers fully exited Equinix in Q4 2019, selling an estimated $67K.
  • Virtus Alternative Investment Advisers's ten largest holdings make up 68% of its $6.65M portfolio in Q4 2019.
  • Virtus Alternative Investment Advisers opened 239 new positions and closed 5 in Q4 2019.
  • Virtus Alternative Investment Advisers's portfolio value rose 43% quarter-over-quarter to $6.65M.

Based on Virtus Alternative Investment Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.